![Christopher Mitton](https://cdn.zonebourse.com/static/resize/768/576//static/images/insiders/unknown.png)
Christopher Mitton
Algemeen Directeur bij MDNA Life Sciences, Inc.
Profiel
Christopher C.
Mitton is currently the Chief Executive Officer & Director at MDNA Life Sciences, Inc. His former job was as Head-Sales Operations at Cancer Genetics, Inc. He obtained an undergraduate degree from Florida A&M University.
Actieve functies van Christopher Mitton
Bedrijven | Functie | Begin |
---|---|---|
MDNA Life Sciences, Inc.
![]() MDNA Life Sciences, Inc. Medical/Nursing ServicesHealth Services MDNA Life Sciences, Inc. engages in the development of molecular tests based on the mitochondrial genome. It focuses on the development and commercial application of mitochondrial DNA based biomarkers for the early detection of prostate, ovarian and lung cancers, and endometriosis. The company was founded by Mark Birch-Machin, Robert Thayer, and Ryan L. Parr in 2001 and is headquartered in West Palm Beach, FL. | Algemeen Directeur | 01-01-2016 |
Eerdere bekende functies van Christopher Mitton
Bedrijven | Functie | Einde |
---|---|---|
CANCER GENETICS, INC. | Corporate Officer/Principal | 01-01-2015 |
Opleiding van Christopher Mitton
Florida A&M University | Undergraduate Degree |
Ervaring
Beklede functies
Actief
Inactief
Beursgenoteerde bedrijven
Bedrijven in privébezit
Connecties
Eerstegraads connecties
Bedrijven verbonden in de eerste graad
Man
Vrouw
Besturend
Uitvoerend
Verwante bedrijven
Bedrijven in privébezit | 2 |
---|---|
MDNA Life Sciences, Inc.
![]() MDNA Life Sciences, Inc. Medical/Nursing ServicesHealth Services MDNA Life Sciences, Inc. engages in the development of molecular tests based on the mitochondrial genome. It focuses on the development and commercial application of mitochondrial DNA based biomarkers for the early detection of prostate, ovarian and lung cancers, and endometriosis. The company was founded by Mark Birch-Machin, Robert Thayer, and Ryan L. Parr in 2001 and is headquartered in West Palm Beach, FL. | Health Services |
Cancer Genetics, Inc.
![]() Cancer Genetics, Inc. Medical SpecialtiesHealth Technology Cancer Genetics, Inc. engages in the development, commercialization, and sale of molecular and biomarker-based tests and services. Through its Select One Clinical Trials program, the firm provides a range of clinical trial services for both oncology and non-oncology genetic testing such as bioinformatics, biomarker solutions, bio repository solutions, consulting, cytogenetic testing, nucleic acid extraction and purification, flow cytometry, Focus: NGS Panel, gene expression analyses, genotyping, and pharmacogenomics. The company was founded by Raju S. K. Chaganti on April 8, 1999 and is headquartered in Rutherford, NJ. | Health Technology |